MTIP successfully concludes medtech fund

The Basel-based start-up investor MTIP MedTech Innovation Partners concluded its first fund. The original expectation of CHF 40 million has been greatly exceeded.

MTIP successfully concludes medtech fund

MTIP MedTech Innovation Partners announced the final closing of its fund with a volume of nearly CHF 60 million. In addition to institutional investors, hospitals, foundations and private individuals also participated in the fund.

“A first fund of such a magnitude is exceptional for this industry and a major success for our investors and for us,” said Christoph Kausch, MTIP CEO.

The Basel-based investor will now support around ten start-ups from the medical technology sector and support them in their further development. The two first companies have already been found in the German start-ups Coramaze and Reactive Robotics, and the first investments have already been made. 

MTIP is putting special emphasis on patient-related innovations when searching for the next companies and wants its investments to be sustainable in the long-term.

“The close involvement of MTIP in the innovation landscape – starting with university research to practical application in hospitals and through to a good overview of the portfolio strategy of relevant medtech players – is an important success factor for our business model,” said chairperson of the board Felix Grisard.


Read more
Recommend us

Related Content

Premium Partner

Strategic partners

Institutional partner

Official program